Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse 21:00:02 22/07/2024 BST 5-day change 1st Jan Change
147.4 USD +0.92% Intraday chart for Quest Diagnostics Incorporated +1.91% +6.87%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
What disruptions have been reported after the global tech outage? RE
Leerink Adjusts Price Target on Quest Diagnostics to $151 From $141, Maintains Market Perform Rating MT
Truist Securities Adjusts Price Target on Quest Diagnostics to $158 From $150, Maintains Hold Rating MT
Quest Diagnostics to Buy OhioHealth's Outreach Lab Services Business MT
Citigroup Upgrades Quest Diagnostics to Buy From Neutral, Adjusts Price Target to $165 From $145 MT
Quest Diagnostics Incorporated entered into a definitive agreement to acquire Select Laboratory Assets of OhioHealth. CI
Not too hot, not too cold Our Logo
Baird Adjusts Price Target on Quest Diagnostics to $153 From $145, Maintains Neutral Rating MT
ANALYST RECOMMENDATIONS : Tesla, Constellations Brands, Old Dominion, Stellantis, Lloyds... Our Logo
Nephron Adjusts Price Target on Quest Diagnostics to $155 From $152 MT
Quest Diagnostics to Buy LifeLabs From OMERS MT
Quest Diagnostics to Buy LifeLabs From OMERS MT
Quest Diagnostics expands into Canada with nearly $1 bln LifeLabs deal RE
Quest Diagnostics to acquire LifeLabs for $985 million RE
Quest Diagnostics to Acquire Lab Assets From Allina Health MT
Quest Diagnostics Incorporated agreed to acquire Select Laboratory Assets of Allina Health from Allina Health System, Inc. CI
Quest Diagnostics Incorporated entered definitive agreement to acquire Select laboratory assets of Allina Health System, Inc. CI
Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI MT
Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI MT
Quest Diagnostics Incorporated completed the acquisition of Select assets of PathAI Diagnostics. CI
JPMorgan Adjusts Price Target on Quest Diagnostics to $155 From $152 MT
Transcript : Quest Diagnostics Incorporated Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-29-2024 09:20 AM
Declaration of Voting Results by Quest Diagnostics Incorporated CI
Quest Diagnostics Elects Robert B. Carte to Board of Directors CI
Everlasting momentum Our Logo
Chart Quest Diagnostics Incorporated
More charts
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
147.4 USD
Average target price
150.4 USD
Spread / Average Target
+2.09%
Consensus
  1. Stock Market
  2. Equities
  3. DGX Stock
  4. News Quest Diagnostics Incorporated
  5. Argus Adjusts Price Target on Quest Diagnostics to $215 From $163, Keeps Buy Rating